Kuros is a biomedical company focused on developing novel injectable materials for localized therapy

Kuros Biosurgery AG
Technoparkstrasse 1
8005 Zürich

Auf Karte anzeigen
Firmenbeschrieb
Through its expertise in advanced biomaterials, bioactives, and tissue healing, Kuros is bringing new products to the market to repair and regenerate injured or diseased tissue. Kuros is currently developing proprietary products which provide both cellular support and therapeutic drugs to a tissue site with impaired healing. Kuros has unique technology that allows for generation of novel bioactives, potentiation of known bioactives, and localized controlled healing responses. Kuros is concurrently developing novel materials which can be applied via minimally invasive surgery for mechanical support of degenerated or damaged tissue. Kuros has now progressed several products into clinical trials. The versatility of the technology makes it ideal for addressing a number of therapeutic areas, including spinal surgery, dermatology, drug delivery, and infection and pain control, amongst others. The company has formed strategic partnerships with several major technology and healthcare companies, including Baxter Healthcare, the Swiss Federal Institute of Technology, Strathmann, and others.

Gründungsjahr
2000
 
Rechtsform
Aktiengesellschaft (AG)
 
Anzahl Mitarbeiter
40
 


Schlüsselwörter
biomedical surgery therapy tissues
Eintrag erstellt: 05.10.2006, Letzte Änderung: 04.05.2007